Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stemtech (STEK) Shares Outstanding (2020 - 2025)

Stemtech (STEK) has disclosed Shares Outstanding for 6 consecutive years, with $158.9 million as the latest value for Q3 2025.

  • Quarterly Shares Outstanding changed N/A to $158.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $158.9 million through Sep 2025, changed N/A year-over-year, with the annual reading at $135.8 million for FY2024, 29.31% up from the prior year.
  • Shares Outstanding hit $158.9 million in Q3 2025 for Stemtech, up from $142.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $158.9 million in Q3 2025 to a low of $540000.0 in Q2 2021.
  • Historically, Shares Outstanding has averaged $77.8 million across 5 years, with a median of $57.3 million in 2022.
  • Biggest five-year swings in Shares Outstanding: increased 12.66% in 2021 and later surged 8195.49% in 2022.
  • Year by year, Shares Outstanding stood at $44.7 million in 2021, then grew by 19.6% to $53.4 million in 2022, then skyrocketed by 96.45% to $105.0 million in 2023, then rose by 29.31% to $135.8 million in 2024, then increased by 17.04% to $158.9 million in 2025.
  • Business Quant data shows Shares Outstanding for STEK at $158.9 million in Q3 2025, $142.4 million in Q2 2025, and $142.4 million in Q1 2025.